Nutriband/$NTRB
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Nutriband
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. Company operates in two reportable segments namely, Sales of Goods and Services. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.
Ticker
$NTRB
Sector
Primary listing
Employees
-
Headquarters
Website
Nutriband Metrics
BasicAdvanced
$36m
-
-$2.51
-
-
Price and volume
Market cap
$36m
52-week high
$9.21
52-week low
$2.90
Average daily volume
13k
Financial strength
Current ratio
5.259
Quick ratio
4.817
Long term debt to equity
1.172
Total debt to equity
3.885
Interest coverage (TTM)
-234.66%
Profitability
EBITDA (TTM)
-7.988
Gross margin (TTM)
28.35%
Net profit margin (TTM)
-448.39%
Operating margin (TTM)
-452.61%
Management effectiveness
Return on assets (TTM)
-78.18%
Return on equity (TTM)
-145.72%
Valuation
Price to revenue (TTM)
19.538
Price to book
6.01
Price to tangible book (TTM)
8.81
Price to free cash flow (TTM)
-8.077
Free cash flow yield (TTM)
-12.38%
Free cash flow per share (TTM)
-0.366
Growth
Revenue change (TTM)
-24.84%
Earnings per share change (TTM)
179.62%
3-year revenue growth (CAGR)
-4.64%
3-year earnings per share growth (CAGR)
61.90%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.